Mickaël Hiligsmann (M.J.C.)

Li, N., Majoie, M., Evers, S., Rijkers, K., Gubler, F., Rouhl, R., Lazeron, R., Klarenbeek, P., Laskier-Owens, V., & Hiligsmann, M. (2025). Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Journal of Medical Economics, 28(1), 114-123. https://doi.org/10.1080/13696998.2024.2443338

van der Leeuw, R. M., Bouwmeester, N. H., Eva, K. W., Hiligsmann, M., & Teunissen, P. W. (2025). Residents' perceptions of what makes feedback valuable in workplace-based learning: A discrete choice experiment. Medical Education, 59(6), 606-614. https://doi.org/10.1111/medu.15541

Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143

Reginster, J.-Y., Schmidmaier, R., Alokail, M., & Hiligsmann, M. (2025). Cost-effectiveness of opportunistic osteoporosis screening using chest radiographs with deep learning in Germany. Aging Clinical and Experimental Research, 37(1), Article 149. https://doi.org/10.1007/s40520-025-03048-x

Borah, B. J., Pieretti, L. J., Balch, A. J., Wani, R. J., Daly, C. J., Dawoud, D., Hutchins, D., Hiligsmann, M., Peterson, A. M., & Agh, T. (2025). Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions. Value in Health, 28(5), 676-679. https://doi.org/10.1016/j.jval.2025.01.022

Hiligsmann, M., Gotay, C., Sankaranarayanan, J., Lazzaro, C., Agh, T., Maas, L., Yfantopoulos, J., & McMinn, R. (2025). Expert review of pharmacoeconomics and outcomes research: high impact articles from 2024. Expert Review of Pharmacoeconomics & Outcomes Research, 1-3. Advance online publication. https://doi.org/10.1080/14737167.2025.2496217

Wouterse, B., Santos, J. V., & Hiligsmann, M. (2025). Future directions for the economics of prevention. Expert Review of Pharmacoeconomics & Outcomes Research, 1-4. Advance online publication. https://doi.org/10.1080/14737167.2025.2498665

Maas, L., Contreras-Meca, C., Vos, W., & Hiligsmann, M. (2025). Unleashing economic potential of AI-driven technology to prevent adverse events and sub-optimal treatment. Expert Review of Pharmacoeconomics & Outcomes Research. Advance online publication. https://doi.org/10.1080/14737167.2025.2499118

van Uittert, G., Hoogbergen, M., Beaudart, C., Li, N., Boers, M., & Hiligsmann, M. (2025). Patients' health related quality of life after massive weight loss reconstruction in the Netherlands. Expert Review of Pharmacoeconomics & Outcomes Research, 25(4), 517-526. https://doi.org/10.1080/14737167.2024.2393328

Linnenkamp, U., Deininghaus, I., Gontscharuk, V., Andrich, S., Bruene, M., Chernyak, N., Kruse, J., Hiligsmann, M., Hoffmann, B., & Icks, A. (2025). Linked survey and statutory health insurance data evaluating healthcare utilization patterns and associated factors of persons with diabetes in Germany - latent class analysis. Scientific Reports, 15(1), Article 11646. https://doi.org/10.1038/s41598-025-95514-9